Multiple autoimmune phenomena in splenic marginal zone lymphoma [12]

Leukemia and Lymphoma

Volumn 47, Issue 4, 2006, Pages 772-775

  Ziakas, Panayiotis D ^a   Giannouli, Stavroula ^a   Tasidou, Anna ^b   Skopouli, Fotini N ^c   Voulgarelis, Michael ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b EVANGELISMOS HOSPITAL   (Greece)

^c HAROKOPIO UNIVERSITY   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; COLD AGGLUTININ; CORTICOTROPIN; DIFFERENTIATION ANTIGEN; ESTROGEN; INTRINSIC FACTOR; PARIETAL CELL ANTIBODY; PREDNISOLONE; THYROXINE;

ADRENAL INSUFFICIENCY; ADULT; ATROPHIC GASTRITIS; AUTOIMMUNE DISEASE; AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD CELL COUNT; BONE MARROW BIOPSY; CASE REPORT; COOMBS TEST; CORTICOTROPIN BLOOD LEVEL; DIARRHEA; FEMALE; HASHIMOTO DISEASE; HUMAN; LETTER; LYMPHOCYTIC INFILTRATION; LYMPHOMA; MONOCLONAL IMMUNOGLOBULINEMIA; ORTHOSTATIC HYPOTENSION; PANCYTOPENIA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SPLEEN TUMOR; SPLENECTOMY; WEAKNESS;

ADULT; ANTIGENS, CD20; AUTOIMMUNE DISEASES; FEMALE; HUMANS; IMMUNOGLOBULINS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, NON-HODGKIN; SPLEEN; SPLENIC NEOPLASMS; SPLENOMEGALY;

EID: 33646782278     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190500399193     Document Type: Letter

References (30)

1. Laureti S, De Bellis A, Muccitelli VI, Calcinaro F, Bizzarro A, Rossi R, et al. Levels of adrenocortical autoantibodies correlate with the degree of adrenal dysfunction in subjects with preclinical Addison's disease. J Clin Endocrinol Metab 1998;83:3507-3511.
2. Thieblemont C, Felman P, Berger F, Dumontet C, Arnaud P, Hequet O, et al. Treatment of splenic marginal B-cell lymphoma: An analysis of 81 patients. Clin Lymphoma 2002;3:41-47.
3. Thieblemont C, Felman P, Callet-Bauchu E, Traverse-Glehen A, Salles G, Berger F, et al. Splenic marginal-zone lymphoma: A distinct clinical and pathological entity. Lancet Oncol 2003;4:95-103.
4. Isaacson PG, Matutes E, Burke M, Catovsky D. The histopathology of splenic lymphoma with villous lymphocytes. Blood 1994;84:3828-3834.
5. Neufeld M, Maclaren NK, Blizzard RM. Two types of autoimmune Addison's disease associated with different polyglandular autoimmune (PGA) syndrome. Medicine 1981; 60:355-362.
6. Sotsiou F, Bottazzo GF, Doniach D. Immunofluorescence studies on autoantibodies to steroid-producing cells and to germline cells in endocrine disease and infertility. Clin Exp Immunol 1980;39:97-111.
7. Falorni A, Laureti S, Nikoshkov A, Picchio ML, Hallengren B, Vandewalle GL, et al. 21-hydroxylase autoantibodies in adult patients with endocrine autoimmune diseases are highly specific for Addison's disease. Clin Exp Immunol 1997;107:341-346.
8. Betterle C, Volpato M, Smith B, Furmaniak J, Chen S, Greggio NA et al. Adrenal cortex and steroid 21-hydroxylase autoantibodies in adult patients with organ-specific autoimmune diseases: Markers of low progression to clinical Addison's disease. J Clin Endocrinol Metabl 1997;82:932-938.
9. Betterle C, Rossi A, Dalla Pria S, Artifoni A, Pedini B, Gavasso S, et al. Premature ovarian failure: Autoimmunity and natural history. Clin Endocrinol (Oxford) 1993;39:35-43.
10. Straus DJ, Filippa DA, Lieberman PH, Koziner B, Thaler HT, Clarkson BD. The non-Hodgkin's lymphomas: A retrospective clinical and pathologic analysis of 499 cases diagnosed between 1958 and 1969. Cancer 1983;51:101-109.
11. Kipps TJ, Carson D. Autoantibodies in chronic lymphocytic leukemia and related systemic autoimmune disease. Blood 1993;81:2475-2487.
12. Baldini L, Nobile-Orazio E, Guffanti A, Barbieri S, Carpo M, Cro L, et al. Peripheral neuropathy in IgM monoclonal gammopathy and Waldestrom's macroglobulinemia: A frequent complication in elderly males with low MAG-reactive serum monoclonal component. Am J Hematol 1994;45:25-31.
13. Ciando M, Horellou MH, Andonin J, De Carbonnieres C, Conard J, Samama M. Lupus anticoagulant associated with primary malignant lymphoplasmacytic lymphoma of the spleen: A report of four patients. Am J Hematol 1991;38:271-276.
14. Ziakas PD, Giannouli S, Psimenou E, Nakopoulou L, Voulgarelis M. Membranous glomerulonephritis in chronic lymphocytic leukemia. Am J Hematol 2004;76:271-274.
15. Dighiero G, Guilbert B, Fermand JP, Lymberi P, Danon F, Avrameas S. Thirty- six human monoclonal immunoglobulins with antibody activity against cytoskeleton proteins, thyroglobulin, and native DNA: immunologic studies and clinical correlations. Blood 1983;62:264-270.
16. Silverman GJ, Goldfien RD, Chen P, Mageed RA, Jefferis R, Goni F, et al. Idiotypic and subgroup analysis of human monoclonal rheumatoid factors. Implications for structural and genetic basis of autoantibodies in humans. J Clin Invest 1988;82:469-475.
17. Pascual V, Victor K, Spellerberg M, Hamblin TJ, Stevenson FK, Capra JD. VH restriction among human cold agglutinins. The VH4-21 gene segment is required to encode anti-i and anti-i specificities. J Immunol 1992;149:2337-2344.
18. Stevenson FK, Longhurst C, Chapman CJ, Ehrenstein M, Spellerberg MB, Hamblin TJ, et al. Utilization of the VH4-21 gene segment by anti-DNA antibodies from patients with systemic lupus erythematosus. J Autoimmun 1993;6:809-825.
19. Yang Y, Wilson JM. CD40 ligand-dependent T cell activation: Requirement of B7-CD28 signaling through CD40. Science 1996;273:1862-1864.
20. Yellin MJ, Sinning J, Covey LR, ShermanW, Lee JJ, Glickman-Nir E, et al. T lymphocyte T cell-B cell-activating molecule/CD40-L molecules induce normal B cells or chronic lymphocytic leukemia B cells to express CD80 (B7/BB-1) and enhance their costimulatory activity. J Immunol 1994;153:666-674.
21. + T cells: A highly differentiated and apoptosis-prone population. Euro J Immunol 2001;31:1122.
22. + cells: A naturally occurring population of regulatory T cells. Blood 2001; 98:2736.
23. + T cells with regulatory properties from human blood. J Exp Med 2001;193:1303.
24. + T cells with regulatory properties isolated from peripheral blood. J Exp Med 2001;193:1285.
25. + T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med 2001;193:1295.
26. O'Garra A, Vieira P. Regulatory T cells and mechanisms of immune system control. Nat Med 2004;10:801-805.
27. Kriegel MA, Lohmann T, Gabler C, Blank N, Kalden JR, Lorenz HM. Defective suppressor function of human CD4+ CD25+ regulatory T cells in autoimmune polyglandular syndrome type II. J Exp Med 2004;199:1285-1291.
28. Yee C, Biondi A, Wang XH, Iscove NN, de Sousa J, Aarden LA, et al. A possible autocrine role for interleukin-6 in two lymphoma cell lines. Blood 1989;74:798-804.
29. Takeshita M, Sumiyoshi Y, Masuda Y, Ohshima K, Yoshida T, Kikuchi M, Muller H. Cytokine (interleukin-1 alpha, interleukin-1 beta, tumor necrosis factor alpha, and interleukin-6)-possessing cells in lymph nodes of malignant lymphoma. Pathol Res Prac 1993;189:18-25.
30. Muller H, Takeshita M, Krause J, Schuster K, Kikuchi M, Stutte HJ. Immunohistochemical in situ demonstration of cytokines in Hodgkin and non-Hodgkin lymphoma. Verh Dtsch Ges Pathol 1992;76:164-168.